MRSN(Delisted)
Mersana Therapeutics·NASDAQ
--
--(--)
MRSN fundamentals
Mersana Therapeutics (MRSN) released its earnings on Mar 28, 2018: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Mar 28, 2018
EPS
Revenue
Revenue & Expenses
MRSN has released its 2025 Q3 earnings report, with revenue of 11.01M, reflecting a YoY change of -12.61%, and net profit of -7.54M, showing a YoY change of 34.40%. The Sankey diagram below clearly presents MRSN's revenue sources and cost distribution.
Key Indicators
Mersana Therapeutics (MRSN) key financial stats and ratios, covering profitability, financial health, and leverage.
Mersana Therapeutics (MRSN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Mersana Therapeutics (MRSN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Mersana Therapeutics (MRSN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Mersana Therapeutics (MRSN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Mersana Therapeutics (MRSN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
